Physician profile
Michael Berend
NPI 1790761666
$4,027,403.34
in general payments reported to CMS, 2019-2025
10 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925K · 2020: $825K · 2021: $2.3M · 2022: $36.39 · 2023: $55.98 · 2024: $1,084 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746 · Travel and Lodging: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.37 |
| Travel and Lodging | $549.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $4,025,877.72 | 2019-2025 | Rosa, Oxford |
| Medacta USA, INC. | $1,097.90 | 2024-2025 | Gmk Sphere |
| Engage Uni, LLC | $114.00 | 2021 | |
| Avanos Medical | $99.00 | 2024 | Coolief* Cooled Radiofrequency |
| Crossroads Orthopedics, LLC | $67.04 | 2021 | |
| Total Joint Orthopedics, INC. | $55.98 | 2023 | |
| Stryker Corporation | $52.48 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $24.23 | 2022 | |
| Dynasplint Systems INC. | $14.99 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,574,301.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Berend listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.